Analysing the 50% Crash of the World’s 7th Largest Company

Is the most dominant force in US healthcare facing a temporary hurdle or a structural decline?
In this episode of Coffee & Investing with Saurabh, Mayank from our Global Compounders Team joins us to dissect the crisis. We move past the headlines to analyse the underlying business model, the genius of their vertical integration strategy, and whether the return of legendary CEO Stephen Hemsley marks a turning point for the stock.